A detailed history of Cibc Asset Management Inc transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Cibc Asset Management Inc holds 1,875 shares of JAZZ stock, worth $220,481. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,875
Holding current value
$220,481
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$100.57 - $116.37 $188,568 - $218,193
1,875 New
1,875 $208,000
Q1 2024

May 09, 2024

BUY
$115.19 - $132.77 $460 - $531
4 Added 0.19%
2,124 $255,000
Q4 2023

Feb 13, 2024

SELL
$114.26 - $136.0 $16,453 - $19,584
-144 Reduced 6.36%
2,120 $260,000
Q3 2023

Oct 30, 2023

BUY
$122.0 - $145.31 $14,762 - $17,582
121 Added 5.65%
2,264 $293,000
Q2 2023

Aug 14, 2023

BUY
$122.5 - $147.16 $245 - $294
2 Added 0.09%
2,143 $265,000
Q1 2023

May 12, 2023

BUY
$133.98 - $160.47 $286,851 - $343,566
2,141 New
2,141 $313,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.37B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Cibc Asset Management Inc Portfolio

Follow Cibc Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.